Resmetirom and metabolic dysfunction-associated steatohepatitis: perspectives on multidisciplinary management from global healthcare professionals : review
The approval of resmetirom brings great hope to patients with metabolic dysfunction-associated steatohepatitis (MASH). The purpose of this review is to explore its impact on the global health environment. The implementation of multidisciplinary management MASH is proposed.
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
December 2024
|
| In: |
Current obesity reports
Year: 2024, Volume: 13, Issue: 4, Pages: 818-830 |
| ISSN: | 2162-4968 |
| DOI: | 10.1007/s13679-024-00582-z |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s13679-024-00582-z Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s13679-024-00582-z |
| Author Notes: | Kahei Au, Ming-Hua Zheng, Wei-Jei Lee, Omar M. Ghanem, Kamal Mahawar, Asim Shabbir, Carel W. le Roux, Giovanni Targher, Christopher D. Byrne, Yusuf Yilmaz, Luca Valenti, Giada Sebastiani, Sombat Treeprasertsuk, Hannah Xiaoyan Hui, Nasser Sakran, Manoel Galvao Neto, Mohammad Kermansaravi, Lilian Kow, Yosuke Seki, Kwang Wei Tham, Jerry Dang, Ricardo V. Cohen, Christine Stier, Salman AlSabah, Rodolfo J. Oviedo, Sonja Chiappetta, Chetan Parmar, Wah Yang, on behalf of Global Obesity Collaborative |
| Summary: | The approval of resmetirom brings great hope to patients with metabolic dysfunction-associated steatohepatitis (MASH). The purpose of this review is to explore its impact on the global health environment. The implementation of multidisciplinary management MASH is proposed. |
|---|---|
| Item Description: | Online veröffentlicht: 07. August 2024 Gesehen am 04.11.2024 |
| Physical Description: | Online Resource |
| ISSN: | 2162-4968 |
| DOI: | 10.1007/s13679-024-00582-z |